The comparison between transperineal and transrectal ultrasound-guided prostate needle biopsy

Korean Journal of Urology

Volumn 50, Issue 2, 2009, Pages 119-124

  Chae, Yunbyung ^a   Kim, Yong June ^a   Kim, Tongwook ^b   Yun, Seok Joong ^a   Lee, Sang Cheol ^a   Kim, Wun Jae ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Biopsy; Pain measurement; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; HEMATURIA; HEMOSPERMIA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PAIN ASSESSMENT; PROSTATE BIOPSY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; RECTUM HEMORRHAGE; SEPSIS; TRANSPERINEAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSY; TUMOR VOLUME;

EID: 61849116141     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2009.50.2.119     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96
2. Kim JH, Chang SG, Kim YW. Pathologic diagnosis and clinical findings in patients undergoing transrectal prostatic biopsy. Korean J Urol 2000;41:492-9
3. Cancer Registration and Biostatistics Branch, National Cancer Center. Cancer Statistics in Korea. 2007
4. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4
5. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997;50:562-6
6. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998;279:1542-7
7. Cho SH, Kim SI, Park HY. The efficacy of routine sextant prostate biopsy plus selective lesion-directaed prostate biopsy. Korean J Urol 2005;46:700-3
8. Kawakami S, Hyochi N, Yonese J, Yano M, Fujii Y, Kageyama Y, et al. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol 2006;11:127-32
9. Kawakami S, Yamamoto S, Numao N, Ishikawa Y, Kihara K, Fukui I. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol 2007;14:719-24
10. Emiliozzi P, Corsetti A, Tassi B, Federico G, Martini M, Pansadoro V. Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 2003;61:961-6
11. Watanabe M, Hayashi T, Tsushima T, Irie S, Kaneshige T, Kumon H. Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol 2005;12:959-63
12. Miller J, Perumalla C, Heap G. Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg 2005;75:48-50
13. Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, Thompson IM. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 2006;106:320-8
14. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-8
15. Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, et al. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 2001;58:723-8
16. Furuno T, Demura T, Kaneta T, Gotoda H, Muraoka S, Sato T, et al. Difference of cancer core distribution between first and repeat biopsy: in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy. Prostate 2004;58: 76-81
17. Eskew LA, Woodruff RD, Bare RL, McCullough DL. Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol 1998;160:794-6
18. Eskicorapci SY, Tuncay L. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. J Urol 2006;175:1605-12. J Urol 2006;176:2745-6
19. Jeon SB, Zhao, C, Jung YB, Park YK, Park JK. A protocol for transrectal, ultrasonography-guided 41-core prostate needle biopsy. Korean J Urol 2008;49:122-6
20. Kang T, Song C, Song GH, Shin GH, Shin DI, Kim CS, et al. The anatomic distribution and pathological characteristics of prostate cancer: a mapping analysis. Korean J Urol 2006; 47:578-85
21. Hollabaugh RS Jr, Dmochowski RR, Steiner MS. Neuroanatomy of the male rhabdosphincter. Urology 1997;49:426-34
22. Issa MM, Bux S, Chun T, Petros JA, Labadia AJ, Anastasia K, et al. A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: The Emory University experience. J Urol 2000;164:397-9
23. Desgrandchamps F, Meria P, Irani J, Desgrippes A, Teillac P, Le Duc A. The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int 1999;83:1007-9
24. Byun SS, Lee HJ, Ku JH, Park K, Lim DJ, Lee SE, et al. Effect of periprostatic nerve blockade for transrectal ultrasound guided biopsy of the prostate. Korean J Urol 2004;45:663-6
25. Thompson PM, Pryor JP, Williams JP, Eyers DE, Dulake C, Scully MF, et al. The problem of infection after prostatic biopsy: the case for the transperineal approach. Br J Urol 1982;54:736-40
26. Webb JA, Shanmuganathan K, McLean A. Complications of ultrasound-guided transperineal prostate biopsy. A prospective study. Br J Urol 1993;72:775-7